CTKB vs. SMH

Last updated Jun 4, 2026

CTKB (Cytek Biosciences, Inc.) is a stock, while SMH (VanEck Semiconductor ETF) is Semiconductors fund tracking the MVIS US Listed Semiconductor 25 Index. Over the past 3 years, CTKB returned -20.53%/yr vs 64.17%/yr for SMH. At a 0.32 correlation, their price movements are largely independent.

Performance

CTKB vs. SMH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cytek Biosciences, Inc. (CTKB) and VanEck Semiconductor ETF (SMH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CTKB achieves a -19.80% return, which is significantly lower than SMH's 77.13% return.

CTKB

• 1D: -3.34%
• 1M: -13.09%
• YTD: -19.80%
• 6M: -24.44%
• 1Y: 42.11%
• 3Y*: -20.53%
• 5Y*: —
• 10Y*: —

SMH

• 1D: 0.90%
• 1M: 25.87%
• YTD: 77.13%
• 6M: 75.61%
• 1Y: 157.20%
• 3Y*: 64.17%
• 5Y*: 39.21%
• 10Y*: 37.68%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CTKB vs. SMH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CTKB Cytek Biosciences, Inc.	-19.80%	-22.19%	-28.84%	-10.68%	-37.44%	-13.01%
SMH VanEck Semiconductor ETF	77.13%	49.17%	39.10%	73.38%	-33.53%	20.65%

Correlation

The correlation between CTKB and SMH is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (All Time) Calculated using the full available price history since Jul 26, 2021	0.32

Return for Risk

CTKB vs. SMH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CTKB

CTKB Risk / Return Rank: 62
CTKB Sharpe Ratio Rank: 64
CTKB Sortino Ratio Rank: 63
CTKB Omega Ratio Rank: 61
CTKB Calmar Ratio Rank: 61
CTKB Martin Ratio Rank: 63

SMH

SMH Risk / Return Rank: 96
SMH Sharpe Ratio Rank: 98
SMH Sortino Ratio Rank: 95
SMH Omega Ratio Rank: 95
SMH Calmar Ratio Rank: 97
SMH Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CTKB vs. SMH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cytek Biosciences, Inc. (CTKB) and VanEck Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CTKB	SMH	Difference
Sharpe ratio: Return per unit of total volatility	0.68	5.19	-4.50
Sortino ratio: Return per unit of downside risk	1.41	5.22	-3.81
Omega ratio: Gain probability vs. loss probability	1.17	1.72	-0.55
Calmar ratio: Return relative to maximum drawdown	0.99	10.59	-9.61
Martin ratio: Return relative to average drawdown	2.48	40.63	-38.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CTKB vs. SMH - Sharpe Ratio Comparison

The current CTKB Sharpe Ratio is 0.68, which is lower than the SMH Sharpe Ratio of 5.19. The chart below compares the historical Sharpe Ratios of CTKB and SMH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CTKB	SMH	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.68	5.19	-4.50
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	1.13	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.16	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.41	0.34	-0.75

Drawdowns

CTKB vs. SMH - Drawdown Comparison

The maximum CTKB drawdown since its inception was -91.34%, which is greater than SMH's maximum drawdown of -84.96%. Use the drawdown chart below to compare losses from any high point for CTKB and SMH.

Drawdown Indicators

	CTKB	SMH	Difference
Max Drawdown Largest peak-to-trough decline	-91.34%	-84.96%	-6.38%
Max Drawdown (1Y) Largest decline over 1 year	-42.94%	-14.93%	-28.01%
Max Drawdown (3Y) Largest decline over 3 years	-74.55%	-35.74%	-38.81%
Max Drawdown (5Y) Largest decline over 5 years	—	-45.30%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-45.30%	—
Current Drawdown Current decline from peak	-85.50%	0.00%	-85.50%
Average Drawdown Average peak-to-trough decline	-67.89%	-41.09%	-26.80%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.00%	3.89%	+13.11%

Volatility

CTKB vs. SMH - Volatility Comparison

Cytek Biosciences, Inc. (CTKB) has a higher volatility of 21.91% compared to VanEck Semiconductor ETF (SMH) at 11.47%. This indicates that CTKB's price experiences larger fluctuations and is considered to be riskier than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CTKB	SMH	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.91%	11.47%	+10.44%
Volatility (6M) Calculated over the trailing 6-month period	34.90%	24.29%	+10.61%
Volatility (1Y) Calculated over the trailing 1-year period	62.04%	30.56%	+31.48%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	65.74%	35.01%	+30.73%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	65.74%	32.57%	+33.17%

Dividends

CTKB vs. SMH - Dividend Comparison

CTKB has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.17%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CTKB Cytek Biosciences, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SMH VanEck Semiconductor ETF	0.17%	0.31%	0.44%	0.60%	1.18%	0.51%	0.69%	1.50%	1.88%	1.43%	0.80%	2.14%

Frequently Asked Questions

Can I hold both CTKB and SMH in my portfolio?

CTKB and SMH have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CTKB or SMH?

CTKB has higher volatility (21.91%) compared to SMH (11.47%). In terms of maximum drawdown, CTKB dropped -91.34% vs SMH's -84.96%.

Which has better risk-adjusted returns?

SMH currently has the higher Sharpe Ratio (5.19 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.